Completed NA INTERVENTIONAL 3-arm NCT01726426

Modulation of Anaerobic Gut Bacteria of Arsenicosis Patients by Probiotics

Modulation of Anaerobic Gut Bacteria in Palmer Arsenical Keratosis Patients by Supplementation With Probiotics

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Interventions Probiotic

Updated 6 times since 2017 Last updated: May 2, 2014 Started: Apr 30, 2013 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Arsenic Poisoning, this trial is completed. The trial is conducted by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Data source: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh